American CryoStem Corporation   Report issue

For profit Phase 1
Founded: Eatontown NJ United States (2008)

Organization Overview

First Clinical Trial
2014
NCT02326935
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

American CryoStem Corporation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Sclerosis (Phase 1)

Sclerosis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 2